BVX.L

BiVictriX Therapeutics Plc [BVX.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

BVX.L Stock Summary

Top 10 Correlated ETFs

BVX.L


Top 10 Correlated Stocks

BVX.L


In the News

BVX.L Financial details

Company Rating
Neutral
Market Cap
9.49M
Income
-
Revenue
-
Book val./share
0.04
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
17
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
-3.04
Forward P/E
-
PEG
-
P/S
-
P/B
1.92
P/C
375
P/FCF
-3.41
Quick Ratio
8.41
Current Ratio
10.14
Debt / Equity
0.07
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-37.21%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
1.14%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-7.69%
Inst Own
-
Inst Trans
-
ROA
-55%
ROE
-49%
ROC
-0.72%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
86.19M
Shs Float
57.47M
-
-
-
-
Target Price
-
52W Range
0.1105-16.0
52W High
-
52W Low
-
RSI
15
Rel Volume
0.42
Avg Volume
34.9K
Volume
14.57K
Perf Week
-4.26%
Perf Month
-2.17%
Perf Quarter
-10%
Perf Half Y
-19.64%
-
-
-
-
Beta
-0.604
-
-
Volatility
0.25%, 0.17%
Prev Close
0%
Price
11.25
Change
-2.6%

BVX.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.01-0.01-0.01-0.06-0.04
Operating cash flow per share
-0.01-0.010-0.05-0.04
Free cash flow per share
-0.01-0.010-0.05-0.04
Cash per share
000.110.160.05
Book value per share
000.110.160.06
Tangible book value per share
000.110.160.06
Share holders equity per share
000.110.160.06
Interest debt per share
000.010.020
Market cap
16.86M16.86M16.86M11.47M11.24M
Enterprise value
16.65M16.73M10M5.65M8.25M
P/E ratio
-44.6-41.22-39.67-4.9-4.5
Price to sales ratio
00000
POCF ratio
-34.83-47.23-101.56-6.42-4.69
PFCF ratio
-34.83-47.23-73.62-6.26-4.03
P/B Ratio
54.3993.662.281.812.84
PTB ratio
54.3993.662.281.812.84
EV to sales
00000
Enterprise value over EBITDA
-34.68-31.81-19.23-3.88-2.92
EV to operating cash flow
-34.4-46.86-60.24-3.16-3.44
EV to free cash flow
-34.4-46.86-43.67-3.08-2.96
Earnings yield
-0.02-0.02-0.03-0.2-0.22
Free cash flow yield
-0.03-0.02-0.01-0.16-0.25
Debt to equity
000.090.040.07
Debt to assets
000.090.040.07
Net debt to EBITDA
0.440.2513.1941.06
Current ratio
9.133.0823.2517.2610.14
Interest coverage
00-25.79-2.95743.75
Income quality
1.010.680.340.70.81
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
000.380.030.16
Capex to revenue
00000
Capex to depreciation
00-63-1-2.58
Stock based compensation to revenue
00000
Graham number
0.020.020.130.470.23
ROIC
-1.22-2.27-0.05-0.26-0.55
Return on tangible assets
-1.09-1.54-0.05-0.34-0.55
Graham Net
000.110.150.05
Working capital
309K179K7.34M6.16M3.57M
Tangible asset value
310K180K7.41M6.33M3.96M
Net current asset value
309K179K7.34M5.99M3.39M
Invested capital
000.090.040.07
Average receivables
0068K198K412.5K
Average payables
022.5K144K166K90.5K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
0096K547.5270.73
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0000.671.35
Inventory turnover
00000
ROE
-1.22-2.27-0.06-0.37-0.63
Capex per share
0000-0.01

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-06-302021-12-312022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
000-0.02-0.02
Operating cash flow per share
000-0.02-0.02
Free cash flow per share
000-0.02-0.02
Cash per share
0000.050.03
Book value per share
0000.060.04
Tangible book value per share
0000.060.04
Share holders equity per share
0000.060.04
Interest debt per share
00000
Market cap
00011.24M9.92M
Enterprise value
-376K-5.82M-4.3M8.25M8.21M
P/E ratio
000-2.43-2.12
Price to sales ratio
00000
POCF ratio
000-10.45-8.11
PFCF ratio
000-8.84-7.17
P/B Ratio
0002.843.5
PTB ratio
0002.843.5
EV to sales
00000
Enterprise value over EBITDA
000-6.36-6.25
EV to operating cash flow
000-7.67-6.71
EV to free cash flow
000-6.49-5.94
Earnings yield
000-0.1-0.12
Free cash flow yield
000-0.11-0.14
Debt to equity
00.040.050.070.07
Debt to assets
00.040.040.070.06
Net debt to EBITDA
0002.311.3
Current ratio
1.6917.267.4910.146.85
Interest coverage
00000
Income quality
0000.931.04
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
0000.180.13
Capex to revenue
00000
Capex to depreciation
000-1.52-2.11
Stock based compensation to revenue
00000
Graham number
0000.150.13
ROIC
000-0.26-0.36
Return on tangible assets
000-0.26-0.34
Graham Net
0000.050.03
Working capital
234K6.16M4.54M3.57M2.39M
Tangible asset value
-348K6.33M5.05M3.96M2.83M
Net current asset value
-435K5.99M4.54M3.39M2.18M
Invested capital
00.040.050.070.07
Average receivables
000282.5K731.5K
Average payables
301K204K261.5K283K163K
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00078.75253.42
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
0001.140.36
Inventory turnover
00000
ROE
000-0.29-0.41
Capex per share
00000

BVX.L Frequently Asked Questions

What is BiVictriX Therapeutics Plc stock symbol ?

BiVictriX Therapeutics Plc is a GB stock and trading under the symbol BVX.L

What is BiVictriX Therapeutics Plc stock quote today ?

BiVictriX Therapeutics Plc stock price is $11.25 today.

Is BiVictriX Therapeutics Plc stock public?

Yes, BiVictriX Therapeutics Plc is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap